Trial Profile
A Prospective, Controlled, Randomized, Multi-Center, Exploratory Pilot Study Evaluating the Safety and Potential Trends in Efficacy of Adhexil
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 16 May 2014
Price :
$35
*
At a glance
- Drugs Fibrin (Primary)
- Indications Adhesions
- Focus Therapeutic Use
- Sponsors OMRIX Biopharmaceuticals
- 15 May 2014 New trial record